Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 1.25
SYK's Cash to Debt is ranked lower than
62% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SYK: 1.25 )
Ranked among companies with meaningful Cash to Debt only.
SYK' s Cash to Debt Range Over the Past 10 Years
Min: 0.04  Med: 1.86 Max: 164.16
Current: 1.25
0.04
164.16
Equity to Asset 0.52
SYK's Equity to Asset is ranked lower than
68% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SYK: 0.52 )
Ranked among companies with meaningful Equity to Asset only.
SYK' s Equity to Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.63 Max: 0.78
Current: 0.52
0.22
0.78
F-Score: 7
Z-Score: 4.70
M-Score: -2.42
WACC vs ROIC
6.60%
19.74%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 18.71
SYK's Operating margin (%) is ranked higher than
88% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. SYK: 18.71 )
Ranked among companies with meaningful Operating margin (%) only.
SYK' s Operating margin (%) Range Over the Past 10 Years
Min: 12.88  Med: 20.48 Max: 23.92
Current: 18.71
12.88
23.92
Net-margin (%) 14.47
SYK's Net-margin (%) is ranked higher than
84% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SYK: 14.47 )
Ranked among companies with meaningful Net-margin (%) only.
SYK' s Net-margin (%) Range Over the Past 10 Years
Min: 5.32  Med: 15.65 Max: 17.39
Current: 14.47
5.32
17.39
ROE (%) 16.96
SYK's ROE (%) is ranked higher than
86% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. SYK: 16.96 )
Ranked among companies with meaningful ROE (%) only.
SYK' s ROE (%) Range Over the Past 10 Years
Min: 5.84  Med: 18.47 Max: 21.28
Current: 16.96
5.84
21.28
ROA (%) 8.64
SYK's ROA (%) is ranked higher than
82% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. SYK: 8.64 )
Ranked among companies with meaningful ROA (%) only.
SYK' s ROA (%) Range Over the Past 10 Years
Min: 3.08  Med: 13.02 Max: 15.38
Current: 8.64
3.08
15.38
ROC (Joel Greenblatt) (%) 78.70
SYK's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. SYK: 78.70 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SYK' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 43.65  Med: 66.64 Max: 73.6
Current: 78.7
43.65
73.6
Revenue Growth (3Y)(%) 5.80
SYK's Revenue Growth (3Y)(%) is ranked higher than
59% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. SYK: 5.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
SYK' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.8  Med: 12.25 Max: 32.9
Current: 5.8
5.8
32.9
EBITDA Growth (3Y)(%) -5.70
SYK's EBITDA Growth (3Y)(%) is ranked lower than
61% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. SYK: -5.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SYK' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.6  Med: 14.80 Max: 59.4
Current: -5.7
-9.6
59.4
EPS Growth (3Y)(%) -27.00
SYK's EPS Growth (3Y)(%) is ranked lower than
84% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SYK: -27.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SYK' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -42.6  Med: 18.20 Max: 153
Current: -27
-42.6
153
» SYK's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

SYK Guru Trades in Q1 2015

Steven Cohen 85,000 sh (New)
Joel Greenblatt 40,138 sh (New)
Eric Mindich 389,000 sh (New)
Jana Partners 50,000 sh (New)
Jim Simons 245,500 sh (New)
Paul Tudor Jones 17,014 sh (+467.13%)
Ray Dalio 17,433 sh (+47.23%)
Jeremy Grantham 2,378,456 sh (+5.12%)
Vanguard Health Care Fund 1,433,500 sh (unchged)
Louis Moore Bacon 75,000 sh (unchged)
Robert Olstein 73,000 sh (unchged)
Dodge & Cox 3,360 sh (unchged)
Ken Fisher 3,320 sh (-1.37%)
Diamond Hill Capital 986,354 sh (-1.50%)
PRIMECAP Management 295,500 sh (-2.96%)
Yacktman Fund 3,050,000 sh (-11.21%)
Donald Yacktman 6,365,465 sh (-13.21%)
Yacktman Focused Fund 2,300,000 sh (-15.35%)
» More
Q2 2015

SYK Guru Trades in Q2 2015

Louis Moore Bacon 50,000 sh (New)
Ray Dalio 65,733 sh (+277.06%)
Robert Olstein 76,000 sh (+4.11%)
Vanguard Health Care Fund 1,433,500 sh (unchged)
PRIMECAP Management 295,500 sh (unchged)
Dodge & Cox 3,360 sh (unchged)
Eric Mindich 389,000 sh (unchged)
Jana Partners Sold Out
Ken Fisher Sold Out
Steven Cohen Sold Out
Diamond Hill Capital 985,688 sh (-0.07%)
Jeremy Grantham 2,127,956 sh (-10.53%)
Yacktman Fund 2,400,000 sh (-21.31%)
Donald Yacktman 4,883,871 sh (-23.28%)
Yacktman Focused Fund 1,600,000 sh (-30.43%)
Paul Tudor Jones 4,214 sh (-75.23%)
Jim Simons 53,300 sh (-78.29%)
Joel Greenblatt 3,101 sh (-92.27%)
» More
Q3 2015

SYK Guru Trades in Q3 2015

Steven Cohen 255,600 sh (New)
John Hussman 30,000 sh (New)
Louis Moore Bacon 120,000 sh (+140.00%)
Paul Tudor Jones 7,500 sh (+77.98%)
PRIMECAP Management 295,500 sh (unchged)
Vanguard Health Care Fund 1,433,500 sh (unchged)
Dodge & Cox 3,360 sh (unchged)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Eric Mindich Sold Out
Ray Dalio Sold Out
Diamond Hill Capital 923,529 sh (-6.31%)
Yacktman Fund 2,000,000 sh (-16.67%)
Jeremy Grantham 1,690,876 sh (-20.54%)
Robert Olstein 49,000 sh (-35.53%)
Donald Yacktman 3,143,750 sh (-35.63%)
Yacktman Focused Fund 400,000 sh (-75.00%)
» More
Q4 2015

SYK Guru Trades in Q4 2015

Ray Dalio 12,164 sh (New)
Jim Simons 26,100 sh (New)
Pioneer Investments 26,932 sh (New)
Vanguard Health Care Fund 2,498,900 sh (+74.32%)
Robert Olstein 52,000 sh (+6.12%)
Diamond Hill Capital 936,985 sh (+1.46%)
PRIMECAP Management 295,500 sh (unchged)
Yacktman Focused Fund Sold Out
Dodge & Cox Sold Out
John Hussman Sold Out
Jeremy Grantham 1,467,369 sh (-13.22%)
Yacktman Fund 1,700,000 sh (-15.00%)
Donald Yacktman 2,061,165 sh (-34.44%)
» More
» Details

Insider Trades

Latest Guru Trades with SYK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 31.66
SYK's P/E(ttm) is ranked lower than
57% of the 260 Companies
in the Global Medical Devices industry.

( Industry Median: 28.39 vs. SYK: 31.66 )
Ranked among companies with meaningful P/E(ttm) only.
SYK' s P/E(ttm) Range Over the Past 10 Years
Min: 11.31  Med: 25.74 Max: 70.9
Current: 31.66
11.31
70.9
Forward P/E 15.75
SYK's Forward P/E is ranked higher than
65% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 18.42 vs. SYK: 15.75 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 31.66
SYK's PE(NRI) is ranked lower than
60% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 27.40 vs. SYK: 31.66 )
Ranked among companies with meaningful PE(NRI) only.
SYK' s PE(NRI) Range Over the Past 10 Years
Min: 11.3  Med: 26.22 Max: 71.37
Current: 31.66
11.3
71.37
P/B 4.31
SYK's P/B is ranked lower than
79% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SYK: 4.31 )
Ranked among companies with meaningful P/B only.
SYK' s P/B Range Over the Past 10 Years
Min: 2.19  Med: 3.41 Max: 7.3
Current: 4.31
2.19
7.3
P/S 3.73
SYK's P/S is ranked lower than
78% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. SYK: 3.73 )
Ranked among companies with meaningful P/S only.
SYK' s P/S Range Over the Past 10 Years
Min: 2.61  Med: 4.55 Max: 7.21
Current: 3.73
2.61
7.21
PFCF 57.26
SYK's PFCF is ranked lower than
74% of the 205 Companies
in the Global Medical Devices industry.

( Industry Median: 34.47 vs. SYK: 57.26 )
Ranked among companies with meaningful PFCF only.
SYK' s PFCF Range Over the Past 10 Years
Min: 11.63  Med: 19.90 Max: 63.01
Current: 57.26
11.63
63.01
POCF 41.25
SYK's POCF is ranked lower than
81% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 19.47 vs. SYK: 41.25 )
Ranked among companies with meaningful POCF only.
SYK' s POCF Range Over the Past 10 Years
Min: 10.24  Med: 17.03 Max: 42.39
Current: 41.25
10.24
42.39
EV-to-EBIT 30.22
SYK's EV-to-EBIT is ranked lower than
66% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. SYK: 30.22 )
Ranked among companies with meaningful EV-to-EBIT only.
SYK' s EV-to-EBIT Range Over the Past 10 Years
Min: 9  Med: 19.20 Max: 67.1
Current: 30.22
9
67.1
EV-to-EBITDA 24.42
SYK's EV-to-EBITDA is ranked lower than
65% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 16.11 vs. SYK: 24.42 )
Ranked among companies with meaningful EV-to-EBITDA only.
SYK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.2  Med: 15.90 Max: 43.4
Current: 24.42
7.2
43.4
Shiller P/E 33.79
SYK's Shiller P/E is ranked lower than
54% of the 72 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. SYK: 33.79 )
Ranked among companies with meaningful Shiller P/E only.
SYK' s Shiller P/E Range Over the Past 10 Years
Min: 20.27  Med: 30.15 Max: 70.47
Current: 33.79
20.27
70.47
Current Ratio 2.26
SYK's Current Ratio is ranked lower than
57% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. SYK: 2.26 )
Ranked among companies with meaningful Current Ratio only.
SYK' s Current Ratio Range Over the Past 10 Years
Min: 1.61  Med: 2.71 Max: 5.37
Current: 2.26
1.61
5.37
Quick Ratio 1.79
SYK's Quick Ratio is ranked lower than
54% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SYK: 1.79 )
Ranked among companies with meaningful Quick Ratio only.
SYK' s Quick Ratio Range Over the Past 10 Years
Min: 0.98  Med: 2.11 Max: 4.63
Current: 1.79
0.98
4.63
Days Inventory 176.67
SYK's Days Inventory is ranked lower than
63% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. SYK: 176.67 )
Ranked among companies with meaningful Days Inventory only.
SYK' s Days Inventory Range Over the Past 10 Years
Min: 136.76  Med: 155.18 Max: 167.21
Current: 176.67
136.76
167.21
Days Sales Outstanding 60.99
SYK's Days Sales Outstanding is ranked higher than
62% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. SYK: 60.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
SYK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 59.31  Med: 61.46 Max: 62.7
Current: 60.99
59.31
62.7
Days Payable 37.11
SYK's Days Payable is ranked lower than
73% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. SYK: 37.11 )
Ranked among companies with meaningful Days Payable only.
SYK' s Days Payable Range Over the Past 10 Years
Min: 33.46  Med: 45.71 Max: 55.97
Current: 37.11
33.46
55.97

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.45
SYK's Dividend Yield is ranked lower than
57% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. SYK: 1.45 )
Ranked among companies with meaningful Dividend Yield only.
SYK' s Dividend Yield Range Over the Past 10 Years
Min: 0.16  Med: 1.05 Max: 1.66
Current: 1.45
0.16
1.66
Dividend Payout 0.37
SYK's Dividend Payout is ranked higher than
52% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. SYK: 0.37 )
Ranked among companies with meaningful Dividend Payout only.
SYK' s Dividend Payout Range Over the Past 10 Years
Min: 0.18  Med: 0.27 Max: 1.91
Current: 0.37
0.18
1.91
Dividend Growth (3y) 18.70
SYK's Dividend Growth (3y) is ranked higher than
77% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SYK: 18.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
SYK' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 21.85 Max: 81.9
Current: 18.7
0
81.9
Forward Dividend Yield 1.56
SYK's Forward Dividend Yield is ranked lower than
53% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. SYK: 1.56 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 8.76
SYK's Yield on cost (5-Year) is ranked higher than
96% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SYK: 8.76 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
SYK' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.95  Med: 6.26 Max: 9.89
Current: 8.76
0.95
9.89
3-Year Average Share Buyback Ratio 0.60
SYK's 3-Year Average Share Buyback Ratio is ranked higher than
89% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. SYK: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SYK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2  Med: 0.55 Max: 2
Current: 0.6
-3.2
2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 176.96
SYK's Price/Net Current Asset Value is ranked lower than
94% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 8.50 vs. SYK: 176.96 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SYK' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 4.45  Med: 10.29 Max: 153
Current: 176.96
4.45
153
Price/Tangible Book 14.17
SYK's Price/Tangible Book is ranked lower than
87% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 4.04 vs. SYK: 14.17 )
Ranked among companies with meaningful Price/Tangible Book only.
SYK' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.87  Med: 6.90 Max: 632.5
Current: 14.17
2.87
632.5
Price/Projected FCF 1.93
SYK's Price/Projected FCF is ranked higher than
56% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. SYK: 1.93 )
Ranked among companies with meaningful Price/Projected FCF only.
SYK' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.92  Med: 1.73 Max: 112.27
Current: 1.93
0.92
112.27
Price/Median PS Value 1.13
SYK's Price/Median PS Value is ranked lower than
61% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. SYK: 1.13 )
Ranked among companies with meaningful Price/Median PS Value only.
SYK' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.62  Med: 1.09 Max: 1.76
Current: 1.13
0.62
1.76
Price/Graham Number 5.05
SYK's Price/Graham Number is ranked lower than
78% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. SYK: 5.05 )
Ranked among companies with meaningful Price/Graham Number only.
SYK' s Price/Graham Number Range Over the Past 10 Years
Min: 1.25  Med: 3.11 Max: 36.14
Current: 5.05
1.25
36.14
Earnings Yield (Greenblatt) (%) 3.29
SYK's Earnings Yield (Greenblatt) (%) is ranked higher than
64% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. SYK: 3.29 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SYK' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.5  Med: 5.20 Max: 11.1
Current: 3.29
1.5
11.1
Forward Rate of Return (Yacktman) (%) -4.67
SYK's Forward Rate of Return (Yacktman) (%) is ranked lower than
70% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. SYK: -4.67 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
SYK' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -3.8  Med: 15.50 Max: 28.8
Current: -4.67
-3.8
28.8

More Statistics

Revenue(Mil) $9946
EPS $ 3.78
Beta0.71
Short Percentage of Float1.85%
52-Week Range $86.68 - 105.34
Shares Outstanding(Mil)375.52

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 10,474 11,142 11,692
EPS($) 5.62 6.18 6.76
EPS without NRI($) 5.62 6.18 6.76

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SMA, ZMH, STJ, EW » details
Traded in other countries:SYK.Germany, SYK.Switzerland, 0R2S.UK,
Stryker Corporation was incorporated in Michigan in 1946. It is a medical technology company. The Company offers medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products. Its business segments are Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics products consist of implants used in hip and knee joint replacements and trauma and extremities surgeries. The Company supports surgeons with the technology and services needed as the company develops new surgical techniques. The MedSurg products include surgical equipment and surgical navigation systems (Instruments); endoscopic and communications systems (Endoscopy); patient handling and emergency medical equipment (Medical); and reprocessed and remanufactured medical devices (Sustainability) as well as other medical device products used in a variety of medical specialties. The Neurotechnology and Spine products include both neurosurgical and neurovascular devices. Its neurotechnology offering includes products used for minimally invasive endovascular techniques; a comprehensive line of products for traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also develops, manufacture and market spinal implant products including cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. The Company's competitors include Zimmer Holdings, Inc. (Zimmer), DePuy Synthes Company, a subsidiary of Johnson & Johnson, Biomet, Inc.,Smith & Nephew plc (Smith & Nephew), Medtronic, including Covidien. The Company's businesses are subject to varying degrees of governmental regulation in the countries in which the company operates and the general trend is toward increasingly stringent regulation.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK